Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

X
Trial Profile

Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 05 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gallium (68Ga) gozetotide (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Diagnostic use
  • Acronyms PSMA PreRP
  • Most Recent Events

    • 27 Jan 2024 Results (n=277; From December 2015 to December 2019) comparing the prognostic value of presurgical PSMA-PET and pelvic lymph nodes invasion (pN1) for biochemical recurrence (BCR) free-survival (FS) in patients with intermediate-risk to high-risk prostate cancer (PCa) treated with radical prostatectomy (RP) and pelvic lymph node dissection from NCT03368547, NCT02611882, NCT02919111 trials, presented at the 2024 Genitourinary Cancers Symposium.
    • 07 Jun 2022 Results of post-hoc follow-up study from (n = 764; NCT03368547, NCT02611882, NCT02919111) presented at the 58th Annual Meeting of the American Society of Clinical Oncology
    • 31 May 2020 Results determining the accuracy of 68Ga-PSMA-11 PET for the detection of pelvic nodal metastases (N1) compared to histopathology at time of radical prostatectomy (NCT03368547, NCT02611882, NCT02919111) presented at the 56th Annual Meeting of the American Society of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top